O'Shaughnessy Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $173M | Buy |
187,547
+47,927
| +34% | +$48.6M | 0.86% | 14 |
|
|
2025
Q4 | $150M | Buy |
139,620
+14,806
| +12% | +$14.2M | 0.83% | 13 |
|
|
2025
Q3 | $95.2M | Buy |
124,814
+5,224
| +4% | +$3.89M | 0.56% | 24 |
|
|
2025
Q2 | $93.2M | Sell |
119,590
-2,819
| -2% | -$2.19M | 0.64% | 20 |
|
|
2025
Q1 | $101M | Buy |
122,409
+14,433
| +13% | +$12M | 0.81% | 15 |
|
|
2024
Q4 | $83.4M | Sell |
107,976
-561
| -0.5% | -$465K | 0.71% | 22 |
|
|
2024
Q3 | $101M | Buy |
108,537
+2,478
| +2% | +$2.23M | 0.9% | 11 |
|
|
2024
Q2 | $96M | Buy |
106,059
+3,947
| +4% | +$3.16M | 0.99% | 8 |
|
|
2024
Q1 | $79.4M | Buy |
102,112
+6,611
| +7% | +$4.7M | 0.88% | 11 |
|
|
2023
Q4 | $55.7M | Sell |
95,501
-11,541
| -11% | -$6.74M | 0.74% | 19 |
|
|
2023
Q3 | $57.5M | Buy |
107,042
+9,459
| +10% | +$4.87M | 0.85% | 12 |
|
|
2023
Q2 | $45.8M | Buy |
97,583
+9,002
| +10% | +$3.78M | 0.68% | 28 |
|
|
2023
Q1 | $30.4M | Sell |
88,581
-6,103
| -6% | -$2.06M | 0.48% | 54 |
|
|
2022
Q4 | $34.6M | Buy |
94,684
+11,051
| +13% | +$3.92M | 0.56% | 41 |
|
|
2022
Q3 | $27M | Buy |
83,633
+12,731
| +18% | +$4.03M | 0.51% | 49 |
|
|
2022
Q2 | $23M | Buy |
70,902
+15,462
| +28% | +$4.64M | 0.42% | 66 |
|
|
2022
Q1 | $15.9M | Buy |
55,440
+19,298
| +53% | +$4.97M | 0.26% | 105 |
|
|
2021
Q4 | $9.98M | Buy |
36,142
+4,732
| +15% | +$1.2M | 0.18% | 142 |
|
|
2021
Q3 | $7.26M | Buy |
31,410
+7,837
| +33% | +$1.93M | 0.15% | 144 |
|
|
2021
Q2 | $5.41M | Sell |
23,573
-3,076
| -12% | -$618K | 0.11% | 177 |
|
|
2021
Q1 | $4.98M | Sell |
26,649
-192,952
| -88% | -$37.7M | 0.11% | 159 |
|
|
2020
Q4 | $37.1M | Sell |
219,601
-333,397
| -60% | -$49.8M | 1.01% | 21 |
|
|
2020
Q3 | $81.9M | Sell |
552,998
-139,461
| -20% | -$21.6M | 2.46% | 6 |
|
|
2020
Q2 | $114M | Sell |
692,459
-92,727
| -12% | -$14.2M | 3.53% | 1 |
|
|
2020
Q1 | $109M | Buy |
785,186
+133,656
| +21% | +$18.4M | 3.82% | 1 |
|
|
2019
Q4 | $85.6M | Buy |
651,530
+283,552
| +77% | +$32.9M | 1.9% | 10 |
|
|
2019
Q3 | $41.2M | Buy |
367,978
+283,657
| +336% | +$31.6M | 0.98% | 31 |
|
|
2019
Q2 | $9.33M | Buy |
84,321
+70,183
| +496% | +$8.26M | 0.22% | 84 |
|
|
2019
Q1 | $1.83M | Sell |
14,138
-1,468
| -9% | -$179K | 0.04% | 201 |
|
|
2018
Q4 | $1.81M | Buy |
15,606
+6,315
| +68% | +$705K | 0.05% | 194 |
|
|
2018
Q3 | $997K | Buy |
+9,291
| New | +$929K | 0.02% | 261 |
|
|
2016
Q1 | – | Sell |
-56
| Closed | -$5K | – | 980 |
|
|
2015
Q4 | $5K | Sell |
56
-1,564
| -97% | -$130K | ﹤0.01% | 801 |
|
|
2015
Q3 | $136K | Sell |
1,620
-790
| -33% | -$66.7K | ﹤0.01% | 535 |
|
|
2015
Q2 | $201K | Buy |
2,410
+35
| +1% | +$2.67K | ﹤0.01% | 524 |
|
|
2015
Q1 | $173K | Sell |
2,375
-70,443
| -97% | -$5.02M | ﹤0.01% | 527 |
|
|
2014
Q4 | $5.02M | Sell |
72,818
-29,672
| -29% | -$2M | 0.1% | 149 |
|
|
2014
Q3 | $6.65M | Buy |
102,490
+28,231
| +38% | +$1.79M | 0.12% | 134 |
|
|
2014
Q2 | $4.62M | Buy |
74,259
+21,596
| +41% | +$1.29M | 0.09% | 171 |
|
|
2014
Q1 | $3.1M | Sell |
52,663
-30,722
| -37% | -$1.71M | 0.06% | 204 |
|
|
2013
Q4 | $4.25M | Sell |
83,385
-58,758
| -41% | -$2.94M | 0.09% | 160 |
|
|
2013
Q3 | $7.15M | Sell |
142,143
-98,379
| -41% | -$5.15M | 0.17% | 105 |
|
|
2013
Q2 | $11.8M | Buy |
+240,522
| New | +$13.1M | 0.32% | 71 |
|
Other funds holding LLY
VCM
VPM
O'Shaughnessy Asset Management's LLY Position: Q1 2026 in Review
O'Shaughnessy Asset Management increased its Eli Lilly (LLY) stake by 34% in Q1 2026, buying an estimated $48.6M and bringing the position to 187,547 shares worth $173M. The position accounts for 0.86% of the portfolio, ranked #14.
O'Shaughnessy Asset Management first reported a position in LLY in Q2 2013 and has held it in 42 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- O'Shaughnessy Asset Management held 187,547 shares of Eli Lilly worth $173M as of Q1 2026.
- O'Shaughnessy Asset Management bought 47,927 Eli Lilly shares in Q1 2026, an estimated $48.6M.
- Eli Lilly made up 0.86% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #14 holding.
- O'Shaughnessy Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 42 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.